Sign in
4

Changes in Ownership

Edwards Lifesciences Corp Filed Acc 0001225208-25-002619

CVP, Chief Financial Officer sold 11,250 shares at an average $70.78 ($796,327)

  • CVP, Chief Financial Officer acquired 11,250 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Ullem Scott B. · CVP, Chief Financial Officer

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2025-02-28 Exercise or conversion : show line 1 in the form 10b5-1 +11,250 $45.28 $509,363 41,637 D
2025-02-28 Sale : show line 2 in the form 10b5-1 −3,490 $71.38 $249,123 38,147 D
2025-02-28 Sale : show line 3 in the form 10b5-1 −7,760 $70.52 $547,204 30,387 D
Open-market sales · 11,250 sh · avg $70.78 · $796,327

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2025-02-28 Exercise or conversion : show line 4 in the form 10b5-1 Employee Stock Option (Right to Acquire) −11,250 22,500 D
Loading xslF345X05/doc4.xml…